Barun Kumar Maity
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Barun Kumar Maity has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Paul R. Selvin
Center for Biophysics and Quantitative Biology, University of Illinois at Urbana-Champaign
3 shared publications Duncan Nall
Department of Physics University of Illinois at Urbana‐Champaign Urbana 61801 USA
2 shared publications- Sudipta Maiti
Tata Institute of Fundamental Research, Homi Bhabha Road, Colaba, Mumbai 400005, India
2 shared publications Yongjae Lee
Center for the Physics of the Living Cell University of Illinois at Urbana‐Champaign Urbana 61801 USA
2 shared publications- Ahenjeeta Ghosh
Homi Bhabha National Institute Training School Complex Mumbai India
1 shared publication Alice Troitskaia
Center for Biophysics and Quantitative Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA
1 shared publication
Latest Publications
- Open Access
- 17 August 2026
- Published by Wiley in Small Science
- Vol. 6 (8)
Advancement of Peptide‐PAINT: Applications and Current Challenges in Super‐Resolution Imaging
Super‐resolution fluorescence microscopy has revolutionized the ability to probe biomolecular organization at the nanoscale in both fixed and living cells. Among various single‐molecule localization microscopy approaches, Point Accumulation for Imaging in Nanoscale Topography (PAINT) offers a conceptually distinct framework by leveraging transient probe–target interactions rather than fluorophore photo‐physics. Building on implementations such as DNA‐PAINT, Peptide‐PAINT has emerged as a versatile and accessible strategy for imaging protein organization with high specificity. This review provides a comprehensive overview of Peptide‐PAINT, covering its fundamental principles and recent methodological advances, including exchangeable, fluorogenic, and endogenous labeling strategies. We highlight its capability for multiplexed imaging and discuss emerging applications in live‐cell systems. Furthermore, we critically evaluate current limitations, including probe kinetics, orthogonality of peptide pairs, specificity, and intracellular delivery. Finally, we outline future directions for engineering robust, easy‐to‐implement Peptide‐PAINT platforms for quantitative and high‐throughput super‐resolution imaging.
- 17 August 2026
- Published by Wiley in Small Science
- Vol. 6 (8)
Open AccessAdvancement of Peptide‐PAINT: Applications and Current Challenges in Super‐Resolution Imaging
Super‐resolution fluorescence microscopy has revolutionized the ability to probe biomolecular organization at the nanoscale in both fixed and living cells. Among various single‐molecule localization microscopy approaches, Point Accumulation for Imaging in Nanoscale Topography (PAINT) offers a conceptually distinct framework by leveraging transient probe–target interactions rather than fluorophore photo‐physics. Building on implementations such as DNA‐PAINT, Peptide‐PAINT has emerged as a versatile and accessible strategy for imaging protein organization with high specificity. This review provides a comprehensive overview of Peptide‐PAINT, covering its fundamental principles and recent methodological advances, including exchangeable, fluorogenic, and endogenous labeling strategies. We highlight its capability for multiplexed imaging and discuss emerging applications in live‐cell systems. Furthermore, we critically evaluate current limitations, including probe kinetics, orthogonality of peptide pairs, specificity, and intracellular delivery. Finally, we outline future directions for engineering robust, easy‐to‐implement Peptide‐PAINT platforms for quantitative and high‐throughput super‐resolution imaging.
- 16 June 2026
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
Co-Delivery of Chemo and Immune Drugs by Prussian Blue Nanocubes for Combinational Therapy and T 1 − T 2 W MR Imaging of MDA-MB-231
Herein, we present Prussian blue nanocube (PBNC)-based nanoformulation, co-loaded with programmed death ligand 1 (PD-L1)/programmed death protein 1 (PD-1) inhibitor (JQ1) and a chemotherapeutic drug (doxorubicin), to improve triple-negative breast cancer (TNBC) cell treatment through combining immuno-, chemo-, and phototherapy. Mechanistically, the synthesized nanoformulation induces robust pyroptotic cell death (∼86%) with a low IC50 (∼15.71 μg/mL) through the CASP3/NF-κβ /IL-1β signaling pathway and remodels the immunosuppressive microenvironment by restoring extracellular and intracellular pH and ions (Na+, K+, Ca2+). Nanoformulation also exhibits higher relaxivity values (r1 ∼ 3.4353 ± 0.103 and r2 ∼ 6.0711 ± 0.378 mM-1s-1) than commercial contrast agents (MAGNEVIST, GADOVIST, PROHANCE, etc.), indicating its potency as a dual-mode contrast agent for magnetic resonance imaging (MRI). We have also validated a drug co-loading mechanism through a series of molecular dynamics simulations, followed by experimental measurements. Importantly, in vivo studies using a xenograft mouse model demonstrate significant tumor growth inhibition, with the nanoformulation + NIR irradiated group showing the most effective anti-tumor outcome with negligible hepatic, renal, and cardiac toxicities. Taken together, it may be stated that the doxorubicin/JQ1 co-loaded PBNCs might be a potential next-generation anti-TNBC theranostic agent, which combines dual-mode MRI capability and combination therapy with reduced side effects.
- 16 June 2026
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
Co-Delivery of Chemo and Immune Drugs by Prussian Blue Nanocubes for Combinational Therapy and T 1 − T 2 W MR Imaging of MDA-MB-231
Herein, we present Prussian blue nanocube (PBNC)-based nanoformulation, co-loaded with programmed death ligand 1 (PD-L1)/programmed death protein 1 (PD-1) inhibitor (JQ1) and a chemotherapeutic drug (doxorubicin), to improve triple-negative breast cancer (TNBC) cell treatment through combining immuno-, chemo-, and phototherapy. Mechanistically, the synthesized nanoformulation induces robust pyroptotic cell death (∼86%) with a low IC50 (∼15.71 μg/mL) through the CASP3/NF-κβ /IL-1β signaling pathway and remodels the immunosuppressive microenvironment by restoring extracellular and intracellular pH and ions (Na+, K+, Ca2+). Nanoformulation also exhibits higher relaxivity values (r1 ∼ 3.4353 ± 0.103 and r2 ∼ 6.0711 ± 0.378 mM-1s-1) than commercial contrast agents (MAGNEVIST, GADOVIST, PROHANCE, etc.), indicating its potency as a dual-mode contrast agent for magnetic resonance imaging (MRI). We have also validated a drug co-loading mechanism through a series of molecular dynamics simulations, followed by experimental measurements. Importantly, in vivo studies using a xenograft mouse model demonstrate significant tumor growth inhibition, with the nanoformulation + NIR irradiated group showing the most effective anti-tumor outcome with negligible hepatic, renal, and cardiac toxicities. Taken together, it may be stated that the doxorubicin/JQ1 co-loaded PBNCs might be a potential next-generation anti-TNBC theranostic agent, which combines dual-mode MRI capability and combination therapy with reduced side effects.
- Open Access
- 3 February 2023
- Published by Wiley in Small Methods
- Vol. 7 (4) , e2201181
Peptide‐PAINT Using a Transfected‐Docker Enables Live‐ and Fixed‐Cell Super‐Resolution Imaging
Point accumulation for imaging in nanoscale topography (PAINT) is a single‐molecule technique for super‐resolution microscopy, which uses exchangeable single stranded DNA oligos or peptide‐pairs to create blinking phenomenon and achieves ≈5–25 nanometer resolution. Here, it is shown that by transfecting the protein‐of‐interest with a docker‐coil, rather than by adding the docker externally—as is the norm when using DNA tethers or antibodies as dockers—similar localization can be achieved, ≈10 nm. However, using a transfected docker has several experimental advances and simplifications. Most importantly, it allows Peptide‐PAINT to be applied to transfected live cells for imaging surface proteins in mammalian cells and neurons under physiological conditions. The enhanced resolution of Peptide‐PAINT is also shown for organelles in fixed cells to unravel structural details including ≈40‐nm and ≈60‐nm axial repeats in vimentin filaments in the cytoplasm, and fiber shapes of sub‐100‐nm histone‐rich regions in the nucleus.
- 3 February 2023
- Published by Wiley in Small Methods
- Vol. 7 (4) , e2201181
Open AccessPeptide‐PAINT Using a Transfected‐Docker Enables Live‐ and Fixed‐Cell Super‐Resolution Imaging
Point accumulation for imaging in nanoscale topography (PAINT) is a single‐molecule technique for super‐resolution microscopy, which uses exchangeable single stranded DNA oligos or peptide‐pairs to create blinking phenomenon and achieves ≈5–25 nanometer resolution. Here, it is shown that by transfecting the protein‐of‐interest with a docker‐coil, rather than by adding the docker externally—as is the norm when using DNA tethers or antibodies as dockers—similar localization can be achieved, ≈10 nm. However, using a transfected docker has several experimental advances and simplifications. Most importantly, it allows Peptide‐PAINT to be applied to transfected live cells for imaging surface proteins in mammalian cells and neurons under physiological conditions. The enhanced resolution of Peptide‐PAINT is also shown for organelles in fixed cells to unravel structural details including ≈40‐nm and ≈60‐nm axial repeats in vimentin filaments in the cytoplasm, and fiber shapes of sub‐100‐nm histone‐rich regions in the nucleus.
- Open Access
Peptide-PAINT using a transfected-docker enables live- and fixed-cell super-resolution imaging
Point accumulation for imaging in nanoscale topography (PAINT) is a single-molecule technique for super-resolution microscopy, achieving ∼5-25 nanometer resolution. Here we show that by transfecting the protein-of-interest with a docker-coil, rather than by adding the docker externally—as is the norm when using DNA tethers or antibodies as dockers—we can achieve similar localization, ∼10 nm. However, using a transfected docker has several experimental advances and simplifications. Most importantly, it allows Peptide-PAINT to be applied to transfected live cells, including surface proteins in mammalian cells and neurons under physiological conditions. The enhance resolution of Peptide-PAINT is also shown for organelles in fixed cells to unravel structural details including ≈40-nm and ≈60-nm axial repeats in vimentin filaments in the cytoplasm, and fiber shapes of sub-100-nm histone-rich regions in the nucleus.
Open AccessPeptide-PAINT using a transfected-docker enables live- and fixed-cell super-resolution imaging
Point accumulation for imaging in nanoscale topography (PAINT) is a single-molecule technique for super-resolution microscopy, achieving ∼5-25 nanometer resolution. Here we show that by transfecting the protein-of-interest with a docker-coil, rather than by adding the docker externally—as is the norm when using DNA tethers or antibodies as dockers—we can achieve similar localization, ∼10 nm. However, using a transfected docker has several experimental advances and simplifications. Most importantly, it allows Peptide-PAINT to be applied to transfected live cells, including surface proteins in mammalian cells and neurons under physiological conditions. The enhance resolution of Peptide-PAINT is also shown for organelles in fixed cells to unravel structural details including ≈40-nm and ≈60-nm axial repeats in vimentin filaments in the cytoplasm, and fiber shapes of sub-100-nm histone-rich regions in the nucleus.
- 15 August 2022
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 14 (34) , 12463-12475
High-throughput force measurement of individual kinesin-1 motors during multi-motor transport
Molecular motors often work in teams to move a cellular cargo. Yet measuring the forces exerted by each motor is challenging. Using a sensor made with denatured ssDNA and multi-color fluorescence, we measured picoNewtons of forces and nanometer distances exerted by individual constrained kinesin-1 motors acting together while driving a common microtubule in vitro. We find that kinesins primarily exerted less than 1 pN force, even while the microtubule is bypassing artificial obstacles of 20–100 nanometer size. Occasionally, individual forces increase upon encountering obstacles, although at other times they do not, with the cargo continuing in a directional manner. Our high-throughput technique, which can measure forces by many motors simultaneously, is expected to be useful for many different types of molecular motors.
- 15 August 2022
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 14 (34) , 12463-12475
High-throughput force measurement of individual kinesin-1 motors during multi-motor transport
Molecular motors often work in teams to move a cellular cargo. Yet measuring the forces exerted by each motor is challenging. Using a sensor made with denatured ssDNA and multi-color fluorescence, we measured picoNewtons of forces and nanometer distances exerted by individual constrained kinesin-1 motors acting together while driving a common microtubule in vitro. We find that kinesins primarily exerted less than 1 pN force, even while the microtubule is bypassing artificial obstacles of 20–100 nanometer size. Occasionally, individual forces increase upon encountering obstacles, although at other times they do not, with the cargo continuing in a directional manner. Our high-throughput technique, which can measure forces by many motors simultaneously, is expected to be useful for many different types of molecular motors.
- 9 May 2022
- Published by IOP Publishing in Journal of Optics
- Vol. 24 (6) , 064012
Real time imaging of the excitation volume of a multiphoton microscope
Knowledge of the excitation profile in a confocal or multiphoton microscope can improve the image resolution, e.g. by using deconvolution, pixel reassignment or adaptive optics strategies. Here we demonstrate a method by which the scanning beam can be used to place a stationary, virtual ‘guide star’ at any chosen location in the sample, during imaging. This can then be used to directly image the excitation profile. The major advantage of our easy-to-install method, compared to competing methods, is that it can work for non-descanned multiphoton microscopy, the method of choice for deep tissue or ultraviolet imaging. Our experimental results reproduce diffraction theory based calculations in a minimally-scattering sample, and provide detailed information about the aberrated excitation profile in a highly scattering sample.
- 9 May 2022
- Published by IOP Publishing in Journal of Optics
- Vol. 24 (6) , 064012
Real time imaging of the excitation volume of a multiphoton microscope
Knowledge of the excitation profile in a confocal or multiphoton microscope can improve the image resolution, e.g. by using deconvolution, pixel reassignment or adaptive optics strategies. Here we demonstrate a method by which the scanning beam can be used to place a stationary, virtual ‘guide star’ at any chosen location in the sample, during imaging. This can then be used to directly image the excitation profile. The major advantage of our easy-to-install method, compared to competing methods, is that it can work for non-descanned multiphoton microscopy, the method of choice for deep tissue or ultraviolet imaging. Our experimental results reproduce diffraction theory based calculations in a minimally-scattering sample, and provide detailed information about the aberrated excitation profile in a highly scattering sample.
- Open Access
Receptor-independent membrane mediated pathways of serotonin action
Serotonin is a neurotransmitter as well as a somatic signaling molecule, and the serotonergic system is a major target for psychotropic drugs. Serotonin, together with a few related neurotransmitters, has recently been found to exhibit an unexpectedly high lipid membrane affinity 1–3 . It has been conjectured that extrasynaptic serotonin can diffuse in the lipid membrane to efficiently reach remote receptors (and receptors with buried ligand-binding sites) 4 , providing a mechanism for the diffuse ‘volume’ neurotransmission that serotonin is capable of 5–10 . Here we show that membrane binding by serotonin can directly modulate membrane properties and cellular function, independent of its receptor-mediated actions. Atomic force microscopy shows that serotonin binding makes artificial lipid bilayers softer. It induces nucleation of liquid disordered domains inside the raft-like liquid-ordered domains in a ternary bilayer displaying phase separation. Solid-state NMR spectroscopy corroborates this data, revealing a rather homogeneous decrease in the order parameter of the lipid chains in the presence of serotonin. In the RN46A immortalized serotonergic neuronal cell line, extracellular serotonin enhances transferrin receptor endocytosis, an action exerted even in the presence of both broad-spectrum serotonin receptor and transporter inhibitors. Similarly, it increases the binding and internalization of Islet Amyloid Polypeptide (IAPP) oligomers, suggesting a connection between serotonin, which is co-secreted with IAPP by pancreatic beta cells, and the cellular effects of IAPP. Our results uncover a hitherto unknown serotonin-bilayer interaction that can potentiate key cellular processes in a receptor-independent fashion. Therefore, some pathways of serotonergic action may escape potent pharmaceutical agents designed for serotonin transporters or receptors. Conversely, bio-orthogonal serotonin-mimetics may provide a new class of cell-membrane modulators.
Open AccessReceptor-independent membrane mediated pathways of serotonin action
Serotonin is a neurotransmitter as well as a somatic signaling molecule, and the serotonergic system is a major target for psychotropic drugs. Serotonin, together with a few related neurotransmitters, has recently been found to exhibit an unexpectedly high lipid membrane affinity 1–3 . It has been conjectured that extrasynaptic serotonin can diffuse in the lipid membrane to efficiently reach remote receptors (and receptors with buried ligand-binding sites) 4 , providing a mechanism for the diffuse ‘volume’ neurotransmission that serotonin is capable of 5–10 . Here we show that membrane binding by serotonin can directly modulate membrane properties and cellular function, independent of its receptor-mediated actions. Atomic force microscopy shows that serotonin binding makes artificial lipid bilayers softer. It induces nucleation of liquid disordered domains inside the raft-like liquid-ordered domains in a ternary bilayer displaying phase separation. Solid-state NMR spectroscopy corroborates this data, revealing a rather homogeneous decrease in the order parameter of the lipid chains in the presence of serotonin. In the RN46A immortalized serotonergic neuronal cell line, extracellular serotonin enhances transferrin receptor endocytosis, an action exerted even in the presence of both broad-spectrum serotonin receptor and transporter inhibitors. Similarly, it increases the binding and internalization of Islet Amyloid Polypeptide (IAPP) oligomers, suggesting a connection between serotonin, which is co-secreted with IAPP by pancreatic beta cells, and the cellular effects of IAPP. Our results uncover a hitherto unknown serotonin-bilayer interaction that can potentiate key cellular processes in a receptor-independent fashion. Therefore, some pathways of serotonergic action may escape potent pharmaceutical agents designed for serotonin transporters or receptors. Conversely, bio-orthogonal serotonin-mimetics may provide a new class of cell-membrane modulators.